Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Grazia Valsecchi

Showing results (201-210 of 326) with videos related to

Pageof 33
Sort By:
Leukemia Research|June 6, 2013
Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemiaRoberta La Starza, Antonella Lettieri, Valentina Pierini, et al.
Plos One|September 16, 2016
Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral TreatmentGiuseppe Lapadula, Davide Paolo Bernasconi, Salvatore Casari, et al.
BMC Geriatrics|March 29, 2025
Correction: Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian surveyAndrea Cavalli, Antonio De Vincentis, Claudio Pedone, et al.
International Journal of Cardiology|September 19, 2024
Long-term prognostic performance of cardiac magnetic resonance imaging markers versus complicated clinical presentation after an acute myocarditisEnrico Ammirati, Marisa Varrenti, Paola Sormani, et al.
BMC Geriatrics|March 2, 2025
Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian surveyAndrea Cavalli, Antonio De Vincentis, Claudio Pedone, et al.
Epidemiologia E Prevenzione|April 17, 2014
[A set of indicators to monitor the adherence to the guidelines for the diagnosis and treatment of breast cancer]Antonio Russo, Anita Andreano, Emanuela Anghinoni, et al.
Iscience|July 8, 2022
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemiaMarius Külp, Anna Lena Siemund, Patrizia Larghero, et al.
Haematologica|September 29, 2018
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cellsFederica Portale, Giulia Cricrì, Silvia Bresolin, et al.
Pediatric Blood & Cancer|October 2, 2012
The thirteenth international childhood acute lymphoblastic leukemia workshop report: La Jolla, CA, USA, December 7-9, 2011Stephen P Hunger, Andre Baruchel, Andrea Biondi, et al.
Zeitschrift Fur Gesundheitswissenschaften = Journal of Public Health|January 10, 2022
Trends in all-cause mortality of hospitalized patients due to SARS-CoV-2 infection from a monocentric cohort in Milan (Lombardy, Italy)Nicola Ughi, Davide Paolo Bernasconi, Francesca Del Gaudio, et al.
Pageof 33

Showing results (201-210 of 326) with videos related to

Sort By:
Pageof 33
Leukemia Research|June 6, 2013
Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemiaRoberta La Starza, Antonella Lettieri, Valentina Pierini, et al.
Plos One|September 16, 2016
Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral TreatmentGiuseppe Lapadula, Davide Paolo Bernasconi, Salvatore Casari, et al.
BMC Geriatrics|March 29, 2025
Correction: Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian surveyAndrea Cavalli, Antonio De Vincentis, Claudio Pedone, et al.
International Journal of Cardiology|September 19, 2024
Long-term prognostic performance of cardiac magnetic resonance imaging markers versus complicated clinical presentation after an acute myocarditisEnrico Ammirati, Marisa Varrenti, Paola Sormani, et al.
BMC Geriatrics|March 2, 2025
Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian surveyAndrea Cavalli, Antonio De Vincentis, Claudio Pedone, et al.
Epidemiologia E Prevenzione|April 17, 2014
[A set of indicators to monitor the adherence to the guidelines for the diagnosis and treatment of breast cancer]Antonio Russo, Anita Andreano, Emanuela Anghinoni, et al.
Iscience|July 8, 2022
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemiaMarius Külp, Anna Lena Siemund, Patrizia Larghero, et al.
Haematologica|September 29, 2018
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cellsFederica Portale, Giulia Cricrì, Silvia Bresolin, et al.
Pediatric Blood & Cancer|October 2, 2012
The thirteenth international childhood acute lymphoblastic leukemia workshop report: La Jolla, CA, USA, December 7-9, 2011Stephen P Hunger, Andre Baruchel, Andrea Biondi, et al.
Zeitschrift Fur Gesundheitswissenschaften = Journal of Public Health|January 10, 2022
Trends in all-cause mortality of hospitalized patients due to SARS-CoV-2 infection from a monocentric cohort in Milan (Lombardy, Italy)Nicola Ughi, Davide Paolo Bernasconi, Francesca Del Gaudio, et al.
Pageof 33